SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238(4826): 491497.
  • 2
    Haubner R, Finsinger D, Kessler H. Stereoisomeric peptide libraries and peptidomimetics for designing selective inhibitors of the alpha(V)beta(3) integrin for a new cancer therapy. Angew Chem Int Edn 1997; 36(13–14): 13751389.
  • 3
    Haubner R, Wester HJ, Weber WA, Mang C, Ziegler SI, Goodman SL, Senekowitsch-Schmidtke R, Kessler H, Schwaiger M. Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 2001; 61(5): 17811785.
  • 4
    Beer AJ, Haubner R, Goebel M, Luderschmidt S, Spilker ME, Wester HJ, Weber WA, Schwaiger M. Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. J Nucl Med 2005; 46(8): 13331341.
  • 5
    Haubner R, Weber WA, Beer AJ, Vabuliene E, Reim D, Sarbia M, Becker KF, Goebel M, Hein R, Wester HJ, Kessler H, Schwaiger M. Noninvasive visualization of the activated alpha v beta 3 integrin in cancer patients by positron emission tomography and [F-18]Galacto-RGD. PLoS Med 2005; 2(3): 244252.
  • 6
    Morrison MS, Ricketts SA, Barnett J, Cuthbertson A, Tessier J, Wedge SR. Use of a novel Arg–Gly–Asp Radioligand, (18)F-AH111585, to determine changes in tumor vascularity after antitumor therapy. J Nucl Med 2009; 50(1): 116122.
  • 7
    McParland BJ, Miller MP, Spinks TJ, Kenny LM, Osman S, Khela MK, Aboagye E, Coombes RC, Hui AM, Cohen PS. The biodistribution and radiation dosimetry of the Arg–Gly–Asp Peptide F-18-AH111585 in healthy volunteers. J Nucl Med 2008; 49(10): 16641667.
  • 8
    Kenny LM, Coombes RC, Oulie I, Contractor KB, Miller M, Spinks TJ, McParland B, Cohen PS, Hui AM, Palmieri C, Osman S, Glaser M, Turton D, At-Nahhas A, Aboagye EO. Phase I trial of the positron-emitting Arg–Gly–Asp (RGD) peptide radioligand F-18-AH111585 in breast cancer patients. J Nucl Med 2008; 49(6): 879886.
  • 9
    Visser EP, Disselhorst JA, Brom M, Laverman P, Gotthardt M, Oyen WJG, Boerman OC. Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med 2009; 50(1): 139147.
  • 10
    Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, Kessler H, Schwaiger M, Wester HJ. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs. J Nucl Med 2004; 45(5): 892902.
  • 11
    Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med 2001; 42(2): 326336.
  • 12
    Schottelius M, Wester HJ, Reubi JC, Senekowitsch-Schmidtke R, Schwaiger M. Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates. Bioconjug Chem 2002; 13(5): 10211030.
  • 13
    Wester HJ, Schottelius M, Scheidhauer K, Reubi JC, Wolf I, Schwaiger M. Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics. Eur J Nucl Med Mol Imag 2002; 29(1): 2838.
  • 14
    Schottelius M, Poethko T, Herz M, Reubi JC, Kessler H, Schwaiger M, Wester HJ. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clin Cancer Res 2004; 10(11): 35933606.
  • 15
    Hultsch C, Schottelius M, Auernheimer J, Alke A, Wester HJ. (18)F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK). Eur J Nucl Med Mol Imaging 2009; 36(9): 14691474.
  • 16
    Namavari M, Cheng Z, Zhang R, De A, Levi J, Hoerner JK, Yaghoubi SS, Syud FA, Gambhir SS. A novel method for direct site-specific radiolabeling of peptides using [18F]FDG. Bioconjug Chem 2009; 20(3): 432436.
  • 17
    Li ZB, Wu Z, Chen K, Chin FT, Chen X. Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression. Bioconjug Chem 2007; 18(6): 19871994.
  • 18
    Schirrmacher E, Wangler B, Cypryk M, Bradtmoller G, Schafer M, Eisenhut M, Jurkschat K, Schirrmacher R. Synthesis of p-(di-tert-butyl[(18)F]fluorosilyl)benzaldehyde ([(18)F]SiFA-A) with high specific activity by isotopic exchange: a convenient labeling synthon for the (18)F-labeling of N-amino-oxy derivatized peptides. Bioconjug Chem 2007; 18(6): 20852089.
  • 19
    Schirrmacher R, Wangler C, Schirrmacher E. Recent developments and trends in F-18-radiochemistry: syntheses and applications. Mini-Rev Org Chem 2007; 4(4): 317329.
  • 20
    Mu L, Hohne A, Schubiger PA, Ametamey SM, Graham K, Cyr JE, Dinkelborg L, Stellfeld T, Srinivasan A, Voigtmann U, Klar U. Silicon-based building blocks for one-step 18F-radiolabeling of peptides for PET imaging. Angew Chem Int Edn Engl 2008; 47(26): 49224925.
  • 21
    Hohne A, Mu L, Honer M, Schubiger PA, Ametamey SM, Graham K, Stellfeld T, Borkowski S, Berndorff D, Klar U, Voigtmann U, Cyr JE, Friebe M, Dinkelborg L, Srinivasan A. Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks. Bioconjug Chem 2008; 19(9): 18711879.
  • 22
    Iovkova L, Wangler B, Schirrmacher E, Schirrmacher R, Quandt G, Boening G, Schurmann M, Jurkschat K. Para-functionalized aryl-di-tert-butylfluorosilanes as potential labeling synthons for (18)F radiopharmaceuticals. Chemistry 2009; 15(9): 21402147.
  • 23
    Rosa-Neto P, Wangler B, Iovkova L, Boening G, Reader A, Jurkschat K, Schirrmacher E. [18F]SiFA-isothiocyanate: a new highly effective radioactive labeling agent for lysine-containing proteins. Chem Biochem 2009; 10(8): 13211324.
  • 24
    Wangler B, Quandt G, Iovkova L, Schirrmacher E, Wangler C, Boening G, Hacker M, Schmoeckel M, Jurkschat K, Bartenstein P, Schirrmacher R. Kit-like 18F-labeling of proteins: synthesis of 4-(di-tert-butyl[18F]fluorosilyl)benzenethiol (Si[18F]FA-SH) labeled rat serum albumin for blood pool imaging with PET. Bioconjug Chem 2009; 20(2): 317321.
  • 25
    Ting R, Harwig C, auf dem Keller U, McCormick S, Austin P, Overall CM, Adam MJ, Ruth TJ, Perrin DM. Toward [18F]-labeled aryltrifluoroborate radiotracers: in vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in mice. J Am Chem Soc 2008; 130(36): 1204512055.
  • 26
    Studenov AR, Adam MJ, Wilson JS, Ruth TJ. New radiolabelling chemistry: synthesis of phosphorus-[F-18]fluorine compounds. J Labelled Compd Rad 2005; 48(7): 497500.
  • 27
    McBride WJ, Sharkey RM, Karacay H, D'Souza CA, Rossi EA, Laverman P, Chang CH, Boerman OC, Goldenberg DM. A novel method of 18F radiolabeling for PET. J Nucl Med 2009; 50(6): 991998.
  • 28
    Laverman P, McBride WJ, Sharkey RM, Eek A, Joosten L, Oyen WJ, Goldenberg DM, Boerman OC. A novel facile method of labeling octreotide with (18)F-fluorine. J Nucl Med 2010; 51(3): 454461.
  • 29
    Knetsch PA, Petrik M, Griessinger CM, Rangger C, Fani M, Kesenheimer C, von Guggenberg E, Pichler BJ, Virgolini I, Decristoforo C, Haubner R. [68Ga]NODAGA-RGD for imaging alphavbeta3 integrin expression. Eur J Nucl Med Mol Imag 2011; 38(7): 13031312.
  • 30
    McBride WJ, D'Souza CA, Sharkey RM, Karacay H, Rossi EA, Chang CH, Goldenberg DM. Improved 18F labeling of peptides with a fluoride–aluminum–chelate complex. Bioconjug Chem 2010; 21(7): 13311340.
  • 31
    Gao H, Lang L, Guo N, Cao F, Quan Q, Hu S, Kiesewetter DO, Niu G, Chen X. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2. Eur J Nucl Med Mol Imaging 2012; 39(4): 683692.
  • 32
    de Sa A, Prata MIM, Geraldes CFGC, Andre JP. Triaza-based amphiphilic chelators: Synthetic route, in vitro characterization and in vivo studies of their Ga(III) and Al(III) chelates. J Inorg Biochem 2010; 104(10): 10511062.
  • 33
    D'Souza CA, McBride WJ, Sharkey RM, Todaro LJ, Goldenberg DM. High-yielding aqueous (18)F-labeling of peptides via Al(18)F chelation. Bioconjug Chem 2011; 22(9): 17931803.
  • 34
    Decristoforo C, Hernandez Gonzalez I, Carlsen J, Rupprich M, Huisman M, Virgolini I, Wester HJ, Haubner R. 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression. Eur J Nucl Med Mol Imaging 2008; 35(8): 15071515.
  • 35
    Liu S, Liu H, Jiang H, Xu Y, Zhang H, Cheng Z. One-step radiosynthesis of (1)F-AlF-NOTA-RGD for tumor angiogenesis PET imaging. Eur J Nucl Med Mol Imaging 2011; 38(9): 17321741.
  • 36
    Lang LX, Li WH, Guo N, Ma Y, Zhu L, Kiesewetter DO, Shen BZ, Niu G, Chen XY. Comparison study of [(18)F]FAI-NOTA-PRGD2, [(18)F]FPPRGD2, and [(68)Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in Mice. Bioconjug Chem 2011; 22(12): 24152422.
  • 37
    Max R, Gerritsen RR, Nooijen PT, Goodman SL, Sutter A, Keilholz U, Ruiter DJ, De Waal RM. Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. Int J Cancer 1997; 71(3): 320324.
  • 38
    Laverman P, D'Souza CA, Eek A, McBride WJ, Sharkey RM, Oyen WJ, Goldenberg DM, Boerman OC. Optimized labeling of NOTA-conjugated octreotide with F-18. Tumour Biol 2012; 33(2): 427434.
  • 39
    Dijkgraaf I, Kruijtzer JA, Liu S, Soede AC, Oyen WJ, Corstens FH, Liskamp RM, Boerman OC. Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides. Eur J Nucl Med Mol Imaging 2007; 34(2): 267273.
  • 40
    van der Have F, Vastenhouw B, Ramakers RM, Branderhorst W, Krah JO, Ji CG, Staelens SG, Beekman FJ. U-SPECT-II: an ultra-high-resolution device for molecular small-animal imaging. J Nucl Med 2009; 50(4): 599605.